Average Co-Inventor Count = 5.82
ph-index = 2
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Institut National De La Sante Et De La Recherche Medicale (6 from 1,743 patents)
2. Université De Lille 2 Droit Et Santé (3 from 13 patents)
3. Alzprotect (3 from 4 patents)
4. Sanofi (1 from 1,451 patents)
5. Innogenetics N.v. (1 from 80 patents)
6. Centre Hospitalier Regional Et Universitaire De Lille (chru) (1 from 9 patents)
7. Universite Du Droit Et De La Santa-lille Ii (1 from 1 patent)
8. Universite De Lille 2 Droit Et Saute (1 from 1 patent)
9. Université De Lille (55 patents)
10. Inserm (0 patent)
11. Universite Du Droit Et De La Sante - Lille Ii (0 patent)
7 patents:
1. 10807958 - 1,4-bis(3-aminopropyl)piperazine derivative and its use
2. 10772884 - Sulphate salts of N-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1H-benzo[d]imidazol-2-amine, preparation thereof and use of the same
3. 10537569 - Sulphate salts of N-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1H-benzo[d]imidazol-2-amine, preparation thereof and use of the same
4. 10017476 - 1,4-bis(3-aminopropyl)piperazine derivative and its use
5. 9562018 - Sulphate salts of N-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1H-benzo[d]imidazol-2-amine, preparation thereof and use of the same
6. 9044478 - Use of 1,4-bis (3-aminoalkyl) piperazine derivatives in the treatment of neurodegenerative diseases
7. 8343493 - Antibodies specific of the β-amyloid peptides and their uses as diagnostic agents or drugs